HILL STEPHEN A

CIK 00012374044 companiesWINSTON-SALEM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001237404

Recent Transactions

50 trades

Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2020-12-16+7,500→ 7,500 total
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2020-12-16+7,500→ 12,750 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2020-06-24+50,000→ 50,000 total
Award
Lipocine Inc.$LPCN
Stock Options (Right to Buy)
2020-06-10$0.96/sh+22,000→ 22,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock
2020-06-04$1.08/sh+18,000→ 18,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2019-06-13+6,500→ 6,500 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2019-06-12$1.68/sh+10,000→ 10,000 total
Sale
Cellectar Biosciences, Inc.$CLRB
Common Stock
2018-11-29$2.21/sh−939→ 53 total
Sale
Cellectar Biosciences, Inc.$CLRB
Common Stock
2018-11-29$2.21/sh−53→ 0 total
Sale
Cellectar Biosciences, Inc.$CLRB
Series A Warrants
2018-11-29$0.10/sh+9,390→ 0 total
Sale
Cellectar Biosciences, Inc.$CLRB
Warrants
2018-11-29$0.05/sh+530→ 0 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2018-10-12+13,000→ 13,000 total
Disposition to Issuer
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2018-09-06$10.07/sh−190→ 1,190 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2018-06-27$1.33/sh+20,000→ 20,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2018-06-13+5,000→ 5,000 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Redeemable Convertible Note
2018-02-20−21,600→ 0 total
Other
GYRE THERAPEUTICS, INC.$GYRE
Redeemable Convertible Note
2018-02-20
Exercise/Conversion
Lipocine Inc.$LPCN
Common Stock
2017-12-29+2,500→ 6,500 total
Exercise/Conversion
Lipocine Inc.$LPCN
Restricted Stock Unit
2017-12-29−2,500→ 7,500 total
Sale
Lipocine Inc.$LPCN
Common stock
2017-12-29$3.47/sh−1,250→ 5,250 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2017-07-13+10,000→ 10,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2017-05-31+10,000→ 10,000 total
Award
Lipocine Inc.$LPCN
Restricted Stock Unit
2017-01-26+10,000→ 10,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2016-07-05$0.01/sh+22,500→ 25,434 total
Award
Lipocine Inc.$LPCN
Common Stock (right to buy)
2016-06-14$8.02/sh+10,000→ 10,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2016-06-09+7,500→ 7,500 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2016-04-20$2.12/sh+9,390→ 9,920 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Series A Warrants
2016-04-20$0.01/sh+9,390→ 9,920 total
Purchase
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2015-12-17$2.03/sh+5,000→ 20,711 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+6,750→ 6,750 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+6,750→ 6,750 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2015-10-22+8,250→ 8,250 total
Tax Payment
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2015-08-28$6.72/sh−12,146→ 15,711 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Redeemable Convertible Note
2015-08-14
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2015-06-16+20,000→ 30,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2015-06-09+5,000→ 5,000 total
Award
Cellectar Biosciences, Inc.$CLRB
Stock option (right to buy)
2015-02-26+5,500→ 5,500 total
Purchase
Lipocine Inc.$LPCN
Common Stock
2014-11-13$4.95/sh+4,000→ 4,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2014-10-17+175,000→ 195,000 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Stock purchase warrant (right to buy)
2014-08-20$0.01/sh+5,300→ 21,351 total
Purchase
Cellectar Biosciences, Inc.$CLRB
Common Stock, par value $0.00001 per share
2014-08-20$3.75/sh+5,300→ 5,300 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2014-01-23+175,000→ 175,000 total
Award
Lipocine Inc.$LPCN
Stock Option (Right to Buy)
2014-01-06+10,000→ 10,000 total
Purchase
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2013-03-11$4.38/sh+10,000→ 20,000 total
Purchase
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2013-03-11$4.38/sh+10,000→ 20,000 total
Purchase
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2013-03-08$4.48/sh+10,000→ 10,000 total
Purchase
GYRE THERAPEUTICS, INC.$GYRE
Common Stock
2013-03-08$4.48/sh+10,000→ 10,000 total
Award
GYRE THERAPEUTICS, INC.$GYRE
Stock Option (Right to Buy)
2012-12-03+400,000→ 400,000 total
Award
ARQULE INC
Employee Stock Options
2005-01-19+125,000→ 815,000 total
Award
ARQULE INC
Employee Stock Options
2004-01-15+150,000→ 690,000 total

Companies

Recent Filings

Address

C/O TARGACEPT, INC. 200 EAST FIRST STREET, SUITE 300

WINSTON-SALEM, NC, 27101

View on SEC.gov